Web Content Management
PRODUCTS
-
Evolve from paper to life sciences digital operations quickly and simply, paving the fastest path to fewer deviations and faster batch releases with data-driven manufacturing.
-
By removing barriers, and bringing trials to patients where they live, we can expand the geographical reach of clinical research across the globe allowing more patients to participate. Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. This approach provides important access to medical care, enhances the inclusivity of clinical trials and advances drug development for all.
-
Our dermatology studies provide results that are more than skin deep. Because the skin is the largest and most easily accessible organ, our dermatology research also facilitates drug development in other areas, including immunology and endocrinology. In addition, we are engaged in studying ways to improve wound healing.
-
Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.
-
In the world of clinical trials, quality is non-negotiable. At inSeption Group, our experienced QA team helps you meet the highest standards from day one.
WHITE PAPERS AND CASE STUDIES
-
Addressing A Global Health Priority In Australia And New Zealand
For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.
-
Revolutionizing Biofilm Research: High-Resolution, Real-Time Imaging with ZeGage Optical Profiler
A university lab optimized biofilm research with Zygo’s ZeGage Optical Profiler, enabling high-resolution, real-time, non-contact imaging that accelerates data collection, enhances accuracy, and preserves biofilm integrity.
-
The Evolution Of Clinical Operations And The Growth Of FSP Partnerships
Explore the integration of new technologies, the FSP’s role in promoting patient diversity, and how clinical operations leaders are increasingly becoming thought leaders within the industry.
-
Preparing The Next Generation Of Clinical Research Professionals
Explore the live EDC platform that enabled Durham Tech to create a model for future-forward, hands-on education in clinical research.
-
How Community Oncologists View CAR T-Cell Therapy Possibilities And Challenges
Learn how a partner with innovative solutions aimed at overcoming the barriers that limit the real-world impact of CAR T-cell therapy can make these advanced therapies more accessible and affordable.
-
A Digital Solution Embeds Quality Into Cellular Therapeutics Production
Discover how Dendreon cut review and release time by nearly 50% while maintaining a 99% right-first-time rate, which boosts collaboration, visibility, and operational efficiency across teams.
-
Quick-Lock Saves Contractor $225,000
Mechanical point repair offers a cost-effective, efficient alternative to traditional lining for fixing pipe defects. These thin-profile stainless-steel sleeves restore structural integrity and seal leaks quickly, significantly reducing project costs while maintaining optimal flow.
-
Understanding Biosafety Levels
Compliance with biosafety levels (BSLs) is crucial in ensuring that your laboratories meet stringent standards to protect staff and prevent the escape of biological agents.
-
Comparing Process Development Approaches For Recombinant Proteins
Explore how adding a traceless tag enables streamlined affinity purification for recombinant proteins, and how this approach compares with a conventional process in development time, recovery, and purity.
-
Richter BioLogics Drives Efficiency And Compliance With Unified Quality
Learn how one CDMO tripled production, improved audit readiness, and built customer trust by unifying quality systems and embracing a digital-first approach.
-
Overcoming Unexpected Obstacles In A Phase 1 Study
Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.
-
What Re-Acquisition In Retinal Imaging Is Really Costing Your Program
High screen failure rates and patient dropout often stem from preventable imaging errors. Learn how proactive quality control and patient-centric logistics secure critical retinal trial data.
NEWS
-
BioLargo Reports Annual 2025 Operating And Financial Results3/11/2026
BioLargo closed 2025 with $3.9 M cash, advanced commercialization across multiple business segments, and grew engineering services revenue 98%, setting the stage for new 2026 opportunities.
-
Focus Universal Inc. Launches Cost-Effective Commercial IoT For Four Sectors12/26/2025
Focus Universal Inc. ("Focus" or the "Company"), a provider of patented hardware and software design technologies for the Internet of Things (IoT), 5G, and AI-driven automation software for SEC financial reporting, is pleased to announce four commcerial IoT are available for commercialization for four sectors.
-
Tribun Health Achieves FDA Clearance For Calopix Digital Pathology Platform With Dual Scanner Compatibility5/21/2025
Tribun Health, a leader in digital pathology, proudly announces that its flagship web-based image management system, CaloPix, has received FDA 510(k) clearance for use with two leading whole slide imaging scanners: the Hamamatsu NanoZoomer S360 and the Leica Aperio GT450.
-
Memorial Hospital Selects CareCloud's HealthLine To Drive Supply Chain Efficiency And Inventory Integrity1/29/2026
CareCloud, Inc. (Nasdaq: CCLD, CCLDO) ("CareCloud" or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced the signing of Memorial Hospital in Marysville, Ohio for its HealthLine supply chain management platform.
-
CytoChip Receives FDA Clearance And First CLIA Waiver For A Cartridge-Based Complete Blood Count Test2/25/2025
CytoChip proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and a CLIA Waiver for its CitoCBC, making it the first cartridge-based CBC test to achieve this milestone.